about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
24.75
-0.09
(-0.36%)
315.7K
XNAS Volume
XNAS 13 May, 2026 4:05 PM (EDT)
Board Meeting
The next board meeting for Septerna Inc is on 15 May 2026 for the purpose of Septerna Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Septerna Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..